rs149918713
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_025193.4(HSD3B7):c.975C>T(p.Ala325=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,606,760 control chromosomes in the GnomAD database, including 181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0094 ( 13 hom., cov: 34)
Exomes 𝑓: 0.013 ( 168 hom. )
Consequence
HSD3B7
NM_025193.4 synonymous
NM_025193.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.05
Genes affected
HSD3B7 (HGNC:18324): (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7) This gene encodes an enzyme which is involved in the initial stages of the synthesis of bile acids from cholesterol and a member of the short-chain dehydrogenase/reductase superfamily. The encoded protein is a membrane-associated endoplasmic reticulum protein which is active against 7-alpha hydrosylated sterol substrates. Mutations in this gene are associated with a congenital bile acid synthesis defect which leads to neonatal cholestasis, a form of progressive liver disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 16-30988048-C-T is Benign according to our data. Variant chr16-30988048-C-T is described in ClinVar as [Benign]. Clinvar id is 261876.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.05 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00938 (1429/152356) while in subpopulation NFE AF= 0.0165 (1122/68026). AF 95% confidence interval is 0.0157. There are 13 homozygotes in gnomad4. There are 716 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSD3B7 | NM_025193.4 | c.975C>T | p.Ala325= | synonymous_variant | 7/7 | ENST00000297679.10 | NP_079469.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSD3B7 | ENST00000297679.10 | c.975C>T | p.Ala325= | synonymous_variant | 7/7 | 1 | NM_025193.4 | ENSP00000297679 | P1 | |
ENST00000624286.1 | n.223G>A | non_coding_transcript_exon_variant | 1/1 | |||||||
HSD3B7 | ENST00000262520.10 | c.*221C>T | 3_prime_UTR_variant | 6/6 | 2 | ENSP00000262520 |
Frequencies
GnomAD3 genomes AF: 0.00939 AC: 1429AN: 152238Hom.: 13 Cov.: 34
GnomAD3 genomes
AF:
AC:
1429
AN:
152238
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00907 AC: 2221AN: 244764Hom.: 16 AF XY: 0.00903 AC XY: 1201AN XY: 132990
GnomAD3 exomes
AF:
AC:
2221
AN:
244764
Hom.:
AF XY:
AC XY:
1201
AN XY:
132990
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0135 AC: 19594AN: 1454404Hom.: 168 Cov.: 64 AF XY: 0.0130 AC XY: 9429AN XY: 723942
GnomAD4 exome
AF:
AC:
19594
AN:
1454404
Hom.:
Cov.:
64
AF XY:
AC XY:
9429
AN XY:
723942
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00938 AC: 1429AN: 152356Hom.: 13 Cov.: 34 AF XY: 0.00961 AC XY: 716AN XY: 74508
GnomAD4 genome
AF:
AC:
1429
AN:
152356
Hom.:
Cov.:
34
AF XY:
AC XY:
716
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at